18 results
8-K
EX-99.1
RGEN
Repligen Corp.
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
and to advance Repligen to the next stage of its development.”
During his tenure at Cytiva, and prior to being named Bioprocess President in 2018, Mr
DEFR14A
RGEN
Repligen Corp.
5 May 21
Revised proxy
4:16pm
DISTRIBUTION
TENURE DISTRIBUTION
GENDER & ETHNIC DIVERSITY
Repligen Corporation
2021 PROXY SUMMARY
CORPORATE GOVERNANCE HIGHLIGHTS
Repligen
8-K
EX-3.1
e598m2b8jot7zb5nhc
28 Jan 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
ah51vlhukw7
15 Jul 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
ymvku4s97n83bj9it
15 Jul 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
8eun17ynt8p
12 Jun 14
Repligen Appoints Nicolas M. Barthelemy to Board of Directors
12:00am
8-K
EX-99.1
dd9dtaopua9qk
21 Sep 12
Repligen Appoints Jonathan I. Lieber as CFO
12:00am
8-K
EX-99.1
dk3ssi25docg7hlkk
25 Aug 09
Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
12:00am
- Prev
- 1
- Next